Pubblicazioni
1) Dalpiaz, A., Fogagnolo, M., Ferraro, L., Beggiato, S., Hanuskova, M., Maretti, E., Sacchetti, F., Leo, E., Pavan, B. Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery (2019) European Journal of Pharmaceutics and Biopharmaceutics, 144, pp. 91-100.
2) Rassu, G., Ferraro, L., Pavan, B., Giunchedi, P., Gavini, E., Dalpiaz, A.The role of combined penetration enhancers in nasal microspheres on in vivo drug bioavailability. (2018) Pharmaceutics, 10 (4), art. no. 206
3) Bonferoni, M.C., Ferraro, L., Pavan, B., Beggiato, S., Cavalieri, E., Giunchedi, P., Dalpiaz, A. Uptake in the central nervous system of geraniol oil encapsulated in chitosan oleate following nasal and oral administration. (2019) Pharmaceutics, 11 (3), art. no. 106.
4) Pavan, B., Dalpiaz, A. Retinal pigment epithelial cells as a therapeutic tool and target against retinopathies. (2018) Drug Discovery Today, 23 (9), pp. 1672-1679.
5) Dalpiaz, A., Pavan, B. Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? (2018) Pharmaceutics, 10 (2), art. no. 39.
6) Trotta, V., Pavan, B., Ferraro, L., Beggiato, S., Traini, D., Des Reis, L.G., Scalia, S., Dalpiaz, A. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles. (2018) European Journal of Pharmaceutics and Biopharmaceutics, 127, pp. 250-259.
7) Pavan, B., Dalpiaz, A., Marani, L., Beggiato, S., Ferraro, L., Canistro, D., Paolini, M., Vivarelli, F., Valerii, M.C., Comparone, A., De Fazio, L.D., Spisni, E. Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes. (2018) Frontiers in Pharmacology, 9 (JAN), art. no. 18.
8) Dalpiaz, A., Ferretti, V., Bertolasi, V., Pavan, B., Monari, A., Pastore, M. From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine. (2018) Molecular Pharmaceutics, 15 (1), pp. 268-278.
9) Pavan, B., Dalpiaz, A. Odorants could elicit repair processes in melanized neuronal and skin cells. (2017) Neural Regeneration Research, 12 (9), pp. 1401-1404.
10) Dalpiaz, A., Pavan, B., Ferretti, V. Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? (2017) Drug Discovery Today, 22 (8), pp. 1134-1138.
11) Pavan, B., Capuzzo, A., Dalpiaz, A. Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells. (2017) Drug Discovery Today, 22 (7), pp. 1123-1130.
12) Marchetti, P., Pavan, B., Simoni, D., Baruchello, R., Rondanin, R., Mischiati, C., Feriotto, G., Ferraro, L., Hsu, L.-C., Lee, R.M., Dalpiaz, A. A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach. (2016) European Journal of Pharmaceutical Sciences, 91, pp. 50-63.
13) Dalpiaz, A., Sacchetti, F., Baldisserotto, A., Pavan, B., Maretti, E., Iannuccelli, V., Leo, E. Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles. (2016) Journal of Drug Delivery Science and Technology, 32, pp. 283-290.
14) Dalpiaz, A., Fogagnolo, M., Ferraro, L., Capuzzo, A., Pavan, B., Rassu, G., Salis, A., Giunchedi, P., Gavini, E. Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries. (2015) Antiviral Research, 123, pp. 146-157.
15) Valerii, M.C., Ricci, C., Spisni, E., Di Silvestro, R., De Fazio, L., Cavazza, E., Lanzini, A., Campieri, M., Dalpiaz, A., Pavan, B., Volta, U., Dinelli, G. Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources. (2015) Food Chemistry, 176, pp. 167-174.
16) Ferretti, V., Dalpiaz, A., Bertolasi, V., Ferraro, L., Beggiato, S., Spizzo, F., Spisni, E., Pavan, B. Indomethacin co-crystals and their parent mixtures: Does the intestinal barrier recognize them differently? (2015) Molecular Pharmaceutics, 12 (5), pp. 1501-1511.
17) Pavan, B., Capuzzo, A., Forlani, G. Quercetin and quercetin-3-O-glucoside interact with different components of the cAMP signaling cascade in human retinal pigment epithelial cells. (2015) Life Sciences, 121, pp. 166-173.
18) Bernareggi, A., Luin, E., Pavan, B., Parato, G., Sciancalepore, M., Urbani, R., Lorenzon, P. Adenosine enhances acetylcholine receptor channel openings and intracellular calcium 'spiking' in mouse skeletal myotubes. (2015) Acta Physiologica, 214 (4), pp. 467-480.
19) Dalpiaz, A., Ferraro, L., Perrone, D., Leo, E., Iannuccelli, V., Pavan, B., Paganetto, G., Beggiato, S., Scalia, S. Brain uptake of a zidovudine prodrug after nasal administration of solid lipid microparticles. (2014) Molecular Pharmaceutics, 11 (5), pp. 1550-1561.
20) Pavan, B., Capuzzo, A., Forlani, G. High glucose-induced barrier impairment of human retinal pigment epithelium is ameliorated by treatment with Goji berry extracts through modulation of cAMP levels. (2014) Experimental Eye Research, 120, pp. 50-54.
21) Pavan, B., Paganetto, G., Rossi, D., Dalpiaz, A. Multidrug resistance in cancer or inefficacy of neuroactive agents: Innovative strategies to inhibit or circumvent the active efflux transporters selectively. (2014) Drug Discovery Today, 19 (10), pp. 1563-1571.
22) Dalpiaz, A., Contado, C., Mari, L., Perrone, D., Pavan, B., Paganetto, G., Hanuskovà, M., Vighi, E., Leo, E. Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid (2014) Drug Delivery, 21 (3), pp. 221-232.
23) Pavan, B., Dalpiaz, A. Dopamine-responsive isoforms of adenylyl cyclase as coincidence detectors in development and function of dopaminergic neurons. (2012) Dopamine: Functions, Regulation and Health Effects, pp. 113-140.
24) Dalpiaz, A., Paganetto, G., Pavan, B., Fogagnolo, M., Medici, A., Beggiato, S., Perrone, D. Zidovudine and ursodeoxycholic acid conjugation: Design of a new prodrug potentially able to bypass the active efflux transport systems of the central nervous system. (2012) Molecular Pharmaceutics, 9 (4), pp. 957-968.
25) Dalpiaz, A., Cacciari, B., Vicentini, C.B., Bortolotti, F., Spalluto, G., Federico, S., Pavan, B., Vincenzi, F., Borea, P.A., Varani, K. A novel conjugated agent between dopamine and an A 2a adenosine receptor antagonist as a potential anti-Parkinson multitarget approach (2012) Molecular Pharmaceutics, 9 (3), pp. 591-604.
26) Dal Monte, M., Martini, D., Latina, V., Pavan, B., Filippi, L., Bagnoli, P. Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity. (2012) Investigative ophthalmology & visual science, 53 (4), pp. 2181-2192.
27) Pavan, B., Dalpiaz, A. Prodrugs and endogenous transporters: Are they suitable tools for drug targeting into the central nervous system? (2011) Current Pharmaceutical Design, 17 (32), pp. 3560-3576.
28) Pavan, B., Paganetto, G., Dalpiaz, A. Dopamine-sensitive adenylyl cyclases in neuronal development: Physiopathological and pharmacological implications. (2011) Drug Discovery Today, 16 (11-12), pp. 520-529.
29) Pavan, B., Paganetto, G., Dalpiaz, A., Biondi, C., Lunghi, L. Estrogen metabolites in the release of inflammatory mediators from human amnion-derived cells. (2011) Life Sciences, 88 (11-12), pp. 551-558.
30) Cervellati, F., Pavan, B., Lunghi, L., Manni, E., Fabbri, E., Mascoli, C., Biondi, C., Patella, A., Vesce, F. Betamethasone, progesterone and RU-486 (mifepristone) exert similar effects on connexin. expression in trophoblast-derived HTR-8/SVneo cells. (2011) Reproduction, Fertility and Development, 23 (2), pp. 319-328.
31) Lunghi, L., Pavan, B., Biondi, C., Paolillo, R., Valerio, A., Vesce, F., Patella, A. Use of glucocorticoids in pregnancy. (2010) Current Pharmaceutical Design, 16 (32), pp. 3616-3637.
32) Biondi, C., Ferretti, M.E., Lunghi, L., Medici, S., Cervellati, F., Pavan, B., Vesce, F., Morano, D., Adinolfi, E., Bertoni, F., Abelli, L. cAMP efflux from human trophoblast cell lines: A role for multidrug resistance protein (MRP)1 transporter. (2010) Molecular Human Reproduction, 16 (7), art. no. gaq023, pp. 481-491.
33) Pavan, B., Biondi, C., Dalpiaz, A. Adenylyl cyclases as innovative therapeutic goals. (2009) Drug Discovery Today, 14 (19-20), pp. 982-991.
34) Dalpiaz, A., Vighi, E., Pavan, B., Leo, E. Fabrication via a nonaqueous nanoprecipitation method, characterization and in vitro biological behavior of N6-cyclopentyladenosine-loaded nanoparticles. (2009) Journal of Pharmaceutical Sciences, 98 (11), pp. 4272-4284.
35) Dalpiaz, A., Pavan, B., Strada, M., Biondi, C., Bortolotti, F., Vertuani, S., Ciliberti, N., Manfredini, S. Conjugation of aspirin with vitamin C: Uptake and stability studies.(2009) Journal of Drug Delivery Science and Technology, 19 (1), pp. 43-50.
36) Pavan, B., Dalpiaz, A., Biondi, C., Nieddu, M., De Luca, A., Prasad, P.D., Paganetto, G., Favaloro, B. An RPE cell line as a useful in vitro model for studying retinoic acid receptor ß :Expression and affinity. (2008) Bioscience Reports, 28 (6), pp. 327-334.
37) Ristori, C., Cammalleri, M., Martini, D., Pavan, B., Liu, Y., Casini, G., Dal Monte, M., Bagnoli, P. Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus. (2008) Naunyn-Schmiedeberg's Archives of Pharmacology, 378 (6), pp. 563-577.
38) Ristori, C., Ferretti, M.E., Pavan, B., Cervellati, F., Casini, G., Catalani, E., Dal Monte, M., Biondi, C. Adenylyl cyclase/cAMP system involvement in the antiangiogenic effect of somatostatin in the retina. Results from transgenic mice. (2008) Neurochemical Research, 33 (7), pp. 1247-1255.
39) Pavan, B., Dalpiaz, A., Ciliberti, N., Biondi, C., Manfredini, S., Vertuani, S. Progress in drug delivery to the central nervous system by the prodrug approach (2008) Molecules, 13 (5), pp. 1035-1065.
40) Ristori, C., Cammalleri, M., Martini, D., Pavan, B., Casini, G., Cervia, D., Bagnoli, P. The cyclooxygenase-2/prostaglandin E2 pathway is involved in the somatostatin-induced decrease of epileptiform bursting in the mouse hippocampus. (2008) Neuropharmacology, 54 (5), pp. 874-884.
41) Dalpiaz, A., Filosa, R., de Caprariis, P., Conte, G., Bortolotti, F., Biondi, C., Scatturin, A., Prasad, P.D., Pavan, B. Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate. (2007) International Journal of Pharmaceutics, 336 (1), pp. 133-139.
42) Biondi, C., Pavan, B., Dalpiaz, A., Medici, S., Lunghi, L., Vesce, F. Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: Effect of steroids, flavonoids and NSAIDs. (2007) Molecular Human Reproduction, 13 (1), pp. 77-83.
43) Pavan, B., Biondi, C., Dalpiaz, A. Nuclear retinoic acid receptor beta as a tool in chemoprevention trials. (2006) Current Medicinal Chemistry, 13 (29), pp. 3553-3563.
44) Pavan, B., Frigato, E., Pozzati, S., Prasad, P.D., Bertolucci, C., Biondi, C. Circadian clocks regulate adenylyl cyclase activity rhythms in human RPE cells. (2006) Biochemical and Biophysical Research Communications, 350 (1), pp. 169-173.
45) Biondi, C., Ferretti, M.E., Pavan, B., Lunghi, L., Gravina, B., Nicoloso, M.S., Vesce, F., Baldassarre, G. Prostaglandin E2 Inhibits Proliferation and Migration of HTR-8/SVneo Cells, a Human Trophoblast-derived Cell Line. (2006) Placenta, 27 (6-7), pp. 592-601.
46) Cammalleri, M., Cervia, D., Monte, M.D., Martini, D., Langenegger, D., Fehlmann, D., Feuerbach, D., Pavan, B., Hoyer, D., Bagnoli, P. Compensatory changes in the hippocampus of somatostatin knockout mice: Upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission (2006) European Journal of Neuroscience, 23 (9), pp. 2404-2422.
47) Leo, E., Contado, C., Bortolotti, F., Pavan, B., Scatturin, A., Tosi, G., Manfredini, S., Angusti, A., Dalpiaz, A. Nanoparticle formulation may affect the stabilization of an antiischemic prodrug. (2006) International Journal of Pharmaceutics, 307 (1), pp. 103-113.
48) Biondi, C., Pavan, B., Dalpiaz, A., Valerio, A., Spisani, S., Vesce, F. Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour. (2005) Journal of Reproductive Immunology, 68 (1-2), pp. 71-83.
49) Biondi, C., Pavan, B., Lunghi, L., Fiorini, S., Vesce, F. The role and modulation of the oxidative balance in pregnancy. (2005) Current Pharmaceutical Design, 11 (16), pp. 2075-2089.
50) Cavicchioni, G., Fraulini, A., Turchetti, M., Varani, K., Falzarano, S., Pavan, B., Spisani, S. Biological activity of for-Met-Leu-Phe-OMe analogs: Relevant substitutions specifically trigger killing mechanisms in human neutrophils. (2005) European Journal of Pharmacology, 512 (1), pp. 1-8.
51) Dalpiaz, A., Leo, E., Vitali, F., Pavan, B., Scatturin, A., Bortolotti, F., Manfredini, S., Durini, E., Forni, F., Brina, B., Vandelli, M.A. Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives (2005) Biomaterials, 26 (11), pp. 1299-1306.
52) Dalpiaz, A., Pavan, B., Scaglianti, M., Vitali, F., Bortolotti, F., Biondi, C., Scatturin, A., Manfredini, S. Vitamin C and 6-amino-vitamin C conjugates of diclofenac: Synthesis and evaluation (2005) International Journal of Pharmaceutics, 291 (1-2), pp. 171-181.
53) Dalpiaz, A., Pavan, B., Vertuani, S., Vitali, F., Scaglianti, M., Bortolotti, F., Biondi, C., Scatturin, A., Tanganelli, S., Ferraro, L., Marzola, G., Prasad, P., Manfredini, S. Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs. (2005) European Journal of Pharmaceutical Sciences, 24 (4), pp. 259-269.
54) Manfredini, S., Vertuani, S., Pavan, B., Vitali, F., Scaglianti, M., Bortolotti, F., Biondi, C., Scatturin, A., Prasad, P., Dalpiaz, A. Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules. (2004) Bioorganic and Medicinal Chemistry, 12 (20), pp. 5453-5463.
55) Pavan, B., Fiorini, S., Dal Monte, M., Lunghi, L., Biondi, C., Bagnoli, P., Cervia, D. Somatostatin coupling to adenylyl cyclase activity in the mouse retina. (2004) Naunyn-Schmiedeberg's Archives of Pharmacology, 370 (2), pp. 91-98.
56) Borasio, P.G., Cervellati, F., Pavan, B., Pareschi, M.C. "Low" concentrations of sodium fluoride inhibit neurotransmitter release from the guinea-pig superior cervical ganglion. (2004) Neuroscience Letters, 364 (2), pp. 86-89.
57) Vesce, F., Pavan, B., Lunghi, L., Giovannini, G., Scapoli, C., Piffanelli, A., Biondi, C. Inhibition of amniotic interleukin-6 and prostaglandin E2 release by ampicillin (2004) Obstetrics and Gynecology, 103 (1), pp. 108-113.
58) Dalpiaz, A., Pavan, B., Scaglianti, M., Vitali, F., Bortolotti, F., Biondi, C., Scatturin, A., Tanganelli, S., Ferraro, L., Prasad, P., Manfredini, S. Transporter-Mediated Effects of Diclofenamic Acid and Its Ascorbyl Pro-drug in the In Vivo. Neurotropic Activity of Ascorbyl Nipecotic Acid Conjugate. (2004) Journal of Pharmaceutical Sciences, 93 (1), pp. 78-85.
59) Dalpiaz, A., Pavan, B., Scaglianti, M., Vitali, F., Bortolotti, F., Biondi, C., Scatturin, A., Manfredini, S. Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C. (2003) Farmacevtski Vestnik, 54 (SPEC. ISS.), pp. 539-540.
60) Fiorini, S., Ferretti, M.E., Biondi, C., Pavan, B., Lunghi, L., Paganetto, G., Abelli, L. 17β-estradiol stimulates arachidonate release from human amnion-like WISH cells through a rapid mechanism involving a membrane receptor. (2003) Endocrinology, 144 (8), pp. 3359-3367.
61) Pavan, B., Fiorini, S., Ferretti, M.E., Vesce, F., Biondi, C. WISH cells as a model for the "in vitro" study of amnion pathophysiology. (2003) Current drug targets. Immune, endocrine and metabolic disorders, 3 (1), pp. 83-92.
62) Biondi, C., Fiorini, S., Pavan, B., Ferretti, M.E., Barion, P., Vesce, F. Interactions between the nitric oxide and prostaglandin E2 biosynthetic pathways in human amnion-like WISH cells. (2003) Journal of Reproductive Immunology, 60 (1), pp. 35-52.
63) Cervia, D., Zizzari, P., Pavan, B., Schuepbach, E., Langenegger, D., Hoyer, D., Biondi, C., Epelbaum, J., Bagnoli, P. Biological activity of somatostatin receptors in GC rat tumour somatotrophs: Evidence with sst1-sst5 receptor-selective nonpeptidyl agonists. (2003) Neuropharmacology, 44 (5), pp. 672-685.
64) Dalpiaz, A., Scatturin, A., Pavan, B., Biondi, C., Vandelli, M.A., Forni, F. Poly(lactic acid) microspheres for the sustained release of antiischemic agents. (2002) International Journal of Pharmaceutics, 242 (1-2), pp. 115-120.
65) Dalpiaz, A., Pavan, B., Ngos, F.N., Franchetti, P., IJzerman, A.P. Temperature dependence of the affinity enhancement of selective adenosine A1 receptor agonism: A thermodynamic analysis. (2002) European Journal of Pharmacology, 448 (2-3), pp. 123-131.
66) Cervia, D., Fiorini, S., Pavan, B., Biondi, C., Bagnoli, P. Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release. (2002) Naunyn-Schmiedeberg's Archives of Pharmacology, 365 (3), pp. 200-209.
67) Manfredini, S., Pavan, B., Vertuani, S., Scaglianti, M., Compagnone, D., Biondi, C., Scatturin, A., Tanganelli, S., Ferraro, L., Prasad, P., Dalpiaz, A. Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity. (2002) Journal of Medicinal Chemistry, 45 (3), pp. 559-562.
68) Dalpiaz, A., Scatturin, A., Pavan, B., Biondi, C., Vandelli, M.A., Forni, F. Poly(lactic acid) microspheres for the sustained release of a selective A1 receptor agonist. (2001) Journal of Controlled Release, 73 (2-3), pp. 303-313.
69) Dalpiaz, A., Scatturin, A., Menegatti, E., Bortolotti, F., Pavan, B., Biondi, C., Durini, E., Manfredini, S. Synthesis and study of 5′-ester prodrugs of N6-cyclopentyladenosine, a selective A1 receptor agonist. (2001) Pharmaceutical Research, 18 (4), pp. 531-536.
70) Ferretti, M.E., Nalli, M., Biondi, C., Colamussi, M.L., Pavan, B., Traniello, S., Spisani, S. Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues. (2001) Cellular Signalling, 13 (4), pp. 233-240.
71) Pavan, B., Biondi, C., Ferretti, M.E., Lunghi, L., Paganetto, G. Phthalic acid mimics 17β-estradiol actions in WISH cells. (2001) Toxicology Letters, 118 (3), pp. 157-164.
72) Pavan, B., Biondi, C., Ferretti, M.E., Lunghi, L., Paganetto, G. 17β-estradiol modulates prostaglandin E2 release from human amnion-derived WISH cells. (2001) Biology of Reproduction, 64 (6), pp. 1677-1681.
73) Biondi, C., Pavan, B., Ferretti, M.E., Corradini, F.G., Neri, L.M., Vesce, F. Formyl-methionyl-leucyl-phenylalanine induces prostaglandin E2 release from human amnion-derived WISH cells by phospholipase C-mediated [Ca2+]i rise. (2001) Biology of Reproduction, 64 (3), pp. 865-870.
74) Pavan, B. Synercid Aventis. (2000) Current Opinion in Investigational Drugs, 1 (2), pp. 173-180.
75) Dalpiaz, A., Scatturin, A., Varani, K., Pecoraro, R., Pavan, B., Borea, P.A. Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands. (2000) Life Sciences, 67 (12), pp. 1517-1524.
76) Pavan, B., Buzzi, M., Ginanni-Corradini, F., Ferretti, M.E., Vesce, F., Biondi, C. Influence of oxytocin on prostaglandin E2, intracellular calcium, and cyclic adenosine monophosphate in human amnion-derived (WISH) cells. (2000) American Journal of Obstetrics and Gynecology, 183 (1), pp. 76-82.
77) Dalpiaz, A., Scatturin, A., Pavan, B., Varani, K., IJzerman, A.P., Borea, P.A. Thermodynamic in vitro studies as a method to investigate the pharmacodynamic behavior of adenosine A1 receptor ligands. (1999) Pharmaceutical Research, 16 (7), pp. 1054-1058.
78) Vesce, F., Pavan, B., Buzzi, M., Pareschi, M.C., Bianciotto, A., Iorizzo, G., Biondi, C. Effect of different classes of antibiotics on amniotic prostaglandin E release (1999) Prostaglandins and Other Lipid Mediators, 57 (4), pp. 207-218.
79) Pavan, B., Ijzerman, A.P. Processing of adenosine receptor agonists in rat and human whole blood (1998) Biochemical Pharmacology, 56 (12), pp. 1625-1632.
80) Vesce, F., Buzzi, M., Ferretti, M.E., Pavan, B., Bianciotto, A., Jorizzo, G., Biondi, C. Inhibition of amniotic prostaglandin E release by ampicillin. (1998) American Journal of Obstetrics and Gynecology, 178 (4), pp. 759-764.
81) Poli, A., Pavan, B., Lucchi, R., Borasio, P.G., Fabbri, E., Rossi, R. Biochemical and pharmacological characterization of adenosine A1 receptors in eel (Anguilla anguilla) brain. (1997) Fish Physiology and Biochemistry, 16 (1), pp. 19-27.
82) Giorgio Borasio, P., Pavan, B., Fabbri, E., Ginanni-Corradini, F., Arcelli, D., Poli, A. Adenosine analogs inhibit acetylcholine release and cyclic AMP synthesis in the guinea-pig superior cervical ganglion. (1995) Neuroscience Letters, 184 (2), pp. 97-100.
